Books

Email : info@nexusalliancebiopharma.com (321) 445-1969

Home
About Us
- R&D Strategy
Pipeline
- SCP Pipeline
- Test Kits
Specific Conjugate Particle Technology
Investor Relations
Publishing
- Articles
- Books
CDA/NDA
Management
Contact

Products

Sale!
TEXTBOOK OF GLOBAL PHARMACOVIGILANCE AND EPIDEMIOLOGY (GPV & E). VOL. I
Buy Now
TEXTBOOK OF IMMUNE-ONCOLOGY IN TREATMENT OF SOLID TUMORS
Buy Now
TEXTBOOK OF IMMUNE-ONCOLOGY IN TREATMENT OF SOLID TUMORS
Buy Now

NAB is a late clinical-stage pharmaceutical company developing the proprietary use of specific conjugate delivery particles,
1800 Pembrook Drive,Orlando, FL 32810
Email: info@nexusalliancebiopharma.com
Telephone: 321-445-1969

Specific Conjugate Particle Technology

SCP Technology
Method Of Delivery
GLIOBLASTOMA
CERVICAL CANCER
SOFT TISSUE SARCOMA

Investor Relations

Expendited Regulatory Approval (505b(2))
SCP Business Case
Safety Assessment Committes (SAC)
SCP-Oncology
SCP-Technology

Publishing

Articles
Books
CONTACT
CDA/NDA

© 2019 NEXUS ALLIANCE BIOPHARMACEUTICALS (NAB) .All rights reserved. Design by: Sunraywebsolutions